Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell Model

Depauw, S; Lambert, M; Jambon, S; Paul, A; Peixoto, P; Nhili, R; Marongiu, L; Figeac, M; Dassi, C; Paul-Constant, C; Billore, B; Kumar, A; Farahat, AA; Ismail, MA; Mineva, E; Sweat, DP; Stephens, CE; Boykin, DW; Wilson, WD; David-Cordonnier, MH

David-Cordonnier, MH (reprint author), Univ Lille, CHU Lille, INSERM, IRCL,JPARC,UMR S1172, F-59045 Lille, France.

JOURNAL OF MEDICINAL CHEMISTRY, 2019; 62 (3): 1306